Q3 2025 Sales Call September 16, 2025 3:30 AM EDTCompany ParticipantsTimo Lehne - CEO & Executive DirectorAndrew Beach - ...

RollsRoyce (RYCEY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings ...

Trading around $34 per share, BP’s leading performance appears appealing, but the underlying narrative is more complex.

Q2 2025 Earnings Call September 17, 2025 5:00 AM EDTCompany ParticipantsGregory Smith - CEO & Executive DirectorMark Reilly ...

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell ...

TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” second ...

While Kooth plc (LON:KOO) might not have the largest market cap around , it saw a decent share price growth of 15% on the AIM over the last few months. The recent rally in share prices has nudged the ...

Cambridge Nutritional Sciences plc (LON:CNSL), might not be a large cap stock, but it received a lot of attention from a substantial price increase on the AIM over the last few months. While good news ...

Unlike traditional automation, agentic AI doesn’t just follow rules. It makes decisions, adapts in real time and learns as it goes. It’s a marriage of intelligent IT automation and robust security, ...

Biodexa Pharmaceuticals PLC Unsponsored ADR (BDRX) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in ...